We are live on ! Find out more
IBIO icon

iBio
IBIO

17 hedge funds and large institutions have $1.16M invested in iBio in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 17 → 17 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

56% less capital invested

Capital invested by funds: $2.67M → $1.16M (-$1.5M)

Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$29.4K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$17.6K
3
HighTower Advisors
HighTower Advisors
Illinois
+$3.92K
4
Morgan Stanley
Morgan Stanley
New York
+$1.96K

Top Sellers

Rank Fund Capital Flow
1
ACP
Arcus Capital Partners
Georgia
-$1.34M
2
VKH
Virtu KCG Holdings
New York
-$29.4K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$23.5K
4
BlackRock
BlackRock
New York
-$21.6K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$5.88K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$656K -$23.5K -12 -3%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$132K – – –
BlackRock
3
BlackRock
New York
$65K -$21.6K -11 -24%
S
4
SignatureFD
Georgia
$59K – – –
HighTower Advisors
5
HighTower Advisors
Illinois
$53K +$3.92K +2 +8%
UBS Group
6
UBS Group
Switzerland
$41K +$29.4K +15 +250%
ACP
7
Aveo Capital Partners
Colorado
$28K – – –
Bank of New York Mellon
8
Bank of New York Mellon
New York
$27K -$5.88K -3 -18%
Northern Trust
9
Northern Trust
Illinois
$27K – – –
Citadel Advisors
10
Citadel Advisors
Florida
$22K -$1.96K -1 -8%
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$18K +$17.6K +9 New
VKH
12
Virtu KCG Holdings
New York
$7K -$29.4K -15 -79%
TSS
13
Two Sigma Securities
New York
$7K -$5.88K -3 -50%
Morgan Stanley
14
Morgan Stanley
New York
$7K +$1.96K +1 +50%
State Street
15
State Street
Massachusetts
$5K – – –
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$4K – – –
UAS
17
United Asset Strategies
New York
$4K – – –
Fifth Third Bancorp
18
Fifth Third Bancorp
Ohio
$1K – – –
ACP
19
Arcus Capital Partners
Georgia
– -$1.34M -621 Closed

IBIO Hedge Fund Activity: Q2 2017 in Review

17 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q2 2017, worth a combined $1.16M — down 56% from $2.67M a quarter earlier.

Fund positioning in IBIO was balanced in Q2 2017: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 6 trimmed.

The largest buyer was UBS Group, adding an estimated $29.4K. The largest seller was Arcus Capital Partners, exiting entirely with an estimated $1.34M sold.

  • 17 institutional investors held iBio (IBIO) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $1.16M of iBio stock for Q2 2017, down 56% quarter-over-quarter.
  • 1 fund opened new iBio positions in Q2 2017 and 1 closed out, a net change of 0 holders.
  • The largest iBio buyer in Q2 2017 was UBS Group, an estimated $29.4K added.
  • The largest iBio seller in Q2 2017 was Arcus Capital Partners, an estimated $1.34M sold.

Based on aggregated 13F filings for Q2 2017.